Technical Analysis for VINC - Vincera Pharma, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.27 | -2.07% | -0.01 |
VINC closed up 0.99 percent on Wednesday, November 20, 2024, on 33 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Bullish Engulfing | Bullish | -2.07% | |
| NR7 | Range Contraction | -2.07% | |
| Narrow Range Bar | Range Contraction | -2.07% | |
| Lower Bollinger Band Walk | Weakness | -2.07% | |
| Inside Day | Range Contraction | -2.07% | |
| Wide Bands | Range Expansion | -2.07% | |
| Lower Bollinger Band Touch | Weakness | -2.07% | |
| Oversold Stochastic | Weakness | -2.07% | |
| New 52 Week Closing Low | Bearish | -1.10% | |
| Doji - Bullish? | Reversal | -1.10% |
| Alert | Time |
|---|---|
| Down 5% | about 2 hours ago |
| Down 3% | about 2 hours ago |
| Fell Below Lower Bollinger Band | about 2 hours ago |
| Fell Below Previous Day's Low | about 2 hours ago |
| New 52 Week Low | about 2 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/12/2024
Vincera Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops new therapies to address unmet medical needs for the treatment of cancer. The company's lead product candidate is VIP152 that is in clinical trials. Its drug candidates are in development for the treatment of solid tumors, leukemia, B-cell malignancies, lymphomas, and myelodysplastic syndrome. Vincera Pharma, Inc. is based in Santa Clara, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Clinical Medicine Solid Tumors Treatment Of Cancer Lymphoma Hematology Leukemia Myelodysplastic Syndrome Anatomical Pathology
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Clinical Medicine Solid Tumors Treatment Of Cancer Lymphoma Hematology Leukemia Myelodysplastic Syndrome Anatomical Pathology
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 9.3722 |
| 52 Week Low | 0.26 |
| Average Volume | 619,156 |
| 200-Day Moving Average | 1.50 |
| 50-Day Moving Average | 0.48 |
| 20-Day Moving Average | 0.33 |
| 10-Day Moving Average | 0.31 |
| Average True Range | 0.03 |
| RSI (14) | 26.47 |
| ADX | 31.79 |
| +DI | 14.03 |
| -DI | 28.09 |
| Chandelier Exit (Long, 3 ATRs) | 0.31 |
| Chandelier Exit (Short, 3 ATRs) | 0.36 |
| Upper Bollinger Bands | 0.40 |
| Lower Bollinger Band | 0.27 |
| Percent B (%b) | 0.07 |
| BandWidth | 41.27 |
| MACD Line | -0.05 |
| MACD Signal Line | -0.05 |
| MACD Histogram | 0.0027 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.30 | ||||
| Resistance 3 (R3) | 0.30 | 0.29 | 0.30 | ||
| Resistance 2 (R2) | 0.29 | 0.28 | 0.29 | 0.29 | |
| Resistance 1 (R1) | 0.28 | 0.28 | 0.29 | 0.28 | 0.29 |
| Pivot Point | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 |
| Support 1 (S1) | 0.27 | 0.27 | 0.27 | 0.27 | 0.26 |
| Support 2 (S2) | 0.26 | 0.26 | 0.26 | 0.26 | |
| Support 3 (S3) | 0.25 | 0.26 | 0.26 | ||
| Support 4 (S4) | 0.25 |
